Literature DB >> 3263798

Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease.

G E Marti1, E T Ryan, N M Papadopoulos, M Filling-Katz, N Barton, T A Fleischer, M Rick, H R Gralnick.   

Abstract

Sera from 23 individuals with Gaucher disease (GD) were analyzed for hypergammaglobulinemia and oligoclonal and monoclonal gammopathies. Serum IgG level was elevated in 15/23 (65%) patients, and a diffuse hypergammaglobulinemia was present in 10/23 (43%) patients. An oligoclonal gammopathy was noted in six patients, and a monoclonal gammopathy in two. Lymphocyte subset analysis was also carried out in eight individuals with GD. Four of five individuals showed increased surface Ig-positive lymphocytes, while 7/7 were positive for either increased CD19- and/or CD20-positive lymphocytes. An eighth patient was found to have a B-cell leukemia. Statistical analysis of kappa and lambda histograms were suggestive of a monoclonal excess. However, restriction enzyme analysis of four individuals with GD and increased B cells failed to show any evidence of Ig gene rearrangements. Serum Ig abnormalities and perhaps B-cell lymphocytosis appear to be common in the GD patient population and are not associated with circulating monoclonal lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263798     DOI: 10.1002/ajh.2830290403

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  19 in total

1.  The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.

Authors:  Tamar H Taddei; Katherine A Kacena; Mei Yang; Ruhua Yang; Advitya Malhotra; Michael Boxer; Kirk A Aleck; Gadi Rennert; Gregory M Pastores; Pramod K Mistry
Journal:  Am J Hematol       Date:  2009-04       Impact factor: 10.047

2.  IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report.

Authors:  C Martinez-Redondo; F J Ortuño; M L Lozano; A Jerez; M del Mar Osma; P Giraldo; V Vicente
Journal:  J Inherit Metab Dis       Date:  2009-06-27       Impact factor: 4.982

3.  Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

Authors:  Hiroki Mizukami; Yide Mi; Ryuichi Wada; Mari Kono; Tadashi Yamashita; Yujing Liu; Norbert Werth; Roger Sandhoff; Konrad Sandhoff; Richard L Proia
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 4.  Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.

Authors:  Madi El Haj; Ami Ben Ya'acov; Gadi Lalazar; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

5.  High incidence of autoantibodies in Fabry disease patients.

Authors:  P Martinez; M Aggio; P Rozenfeld
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

6.  Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.

Authors:  Akira Yamaguchi; Kayoko Katsuyama; Kiyotaka Nagahama; Toshiyuki Takai; Ichiro Aoki; Shoji Yamanaka
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

7.  Progressive liver failure in a patient with adult Niemann-Pick disease associated with generalized AL amyloidosis.

Authors:  H Zhou; R P Linke; H E Schaefer; W Möbius; U Pfeifer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy.

Authors:  Shiny Nair; Noffar Bar; Mina L Xu; Madhav Dhodapkar; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-02-05       Impact factor: 4.797

9.  Leukocyte perturbation associated with Fabry disease.

Authors:  P Rozenfeld; E Agriello; N De Francesco; P Martinez; C Fossati
Journal:  J Inherit Metab Dis       Date:  2009-03-07       Impact factor: 4.982

Review 10.  Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

Authors:  Pramod K Mistry; Tamar Taddei; Stephan vom Dahl; Barry E Rosenbloom
Journal:  Crit Rev Oncog       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.